Big endothelin-1 and big endothelin-3 are constrictor agents in the microvasculature: evidence for the local phosphoramidon-sensitive conversion of big endothelin-1

European Journal of Pharmacology

Volumn 233, Issue 2-3, 1993, Pages 243-250

  Lawrence, Elizabeth ^a   Brain, Susan D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Big endothelin 1; Big endothelin 3; Cheek pouch (hamster); Microcirculation; Phosphoramidon; Skin blood flow (rat)

Indexed keywords

BIG ENDOTHELIN 3; ENDOTHELIN 1; ENDOTHELIN DERIVATIVE; PHOSPHORAMIDON; VASOPRESSIN; XENON 133;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL DIAMETER; CHEEK POUCH; CONTROLLED STUDY; DRUG METABOLISM; HAMSTER; INTRADERMAL DRUG ADMINISTRATION; MALE; MICROSCOPY; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN BLOOD FLOW; VASOCONSTRICTION;

ANIMAL; DRUG INTERACTIONS; ENDOTHELINS; GLYCOPEPTIDES; HAMSTERS; HUMAN; MALE; MESOCRICETUS; MICROCIRCULATION; RATS; RATS, WISTAR; SKIN; SUPPORT, NON-U.S. GOV'T; THERMOLYSIN; VASOCONSTRICTION;

EID: 0027457838     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(93)90056-N     Document Type: Article

References (33)

1. Formation of endothelin by cultured airway epithelial cells
2. cDNA cloning and chromosomal assignment of the gene encoding endothelin-3
3. Endothelin reduces microvascular blood flow by acting on arterioles and venules of the hamster cheek pouch
4. Endothelin induces potent microvascular constriction
5. Endothelin-1: Demonstration of potent effects on the microcirculation of humans and other species
6. Intravascular big endothelin increases circulating levels of endothelin and prostanoids in the rabbit
7. Different pharmacological profiles of big-endothelin-3 and big-endothelin-1 in vivo and in vitro
8. Endothelium-dependent mesenteric vasorelaxant effects and systemic actions of endothelin (16–21) and other endothelin-related peptides in the rat
9. Responses to endothelin-1, human proendothelin (1–38) and porcine proendothelin (1–39) in the rat on intravenous administration and in the blood perfused mesentery
10. The preparation and use of the hamster cheek pouch for studies of the microcirculation
11. Inhibition of biological actions of big endothelin-1 by phosphoramidon
12. The effects of phosphoramidon on the regional haemodynamic responses to human proendothelin [1–38] in conscious rats
13. Inhibition by phosphoramidon of the regional haemodynamic effects of proendothelin-2 and -3 in conscious rats
14. Endothelin-1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia
15. Cheek pouch technology: Uses and applications
16. The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes
17. Putative precursors of endothelin have less vasoconstrictor activity in vitro but a potent pressor effect in vivo
18. Conversion of big endothelin-1 to 21 residue endothelin-1 is essential for expression of full vasoconstrictor activity: Structure-activity relationships of big endothelin-1
19. Responses to endothelins in the rat cutaneous microvasculature: a modulatory role of locally-produced nitric oxide
20. G-nitro-L-arginine methyl ester in streptozotocin-induced diabetes mellitus
21. Abundance of endothelin-3 in rat intestine, pituitary gland and brain
22. Conversion of porcine big endothelin to endothelin by an extract from the porcine aortic endothelial cells
23. Phosphoramidon blocks the pressor activity of porcine big endothelin-1 (1–39) in vivo and conversion of big endothelin-1 (1–39) to endothelin-1 (1–21) in vitro
24. Conversion of big endothelin-1 by membrane bound metalloendopeptidase in cultured bovine endothelial cells
25. Evidence for metalloprotease involvement in the in vivo effects of big endothelin-1
26. Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells
27. Endothelin-3 is a novel neuropeptide: isolation and sequence determination of ET-1 and ET-3 in porcine brain
28. Phosphoramidon inhibits the conversion of intracisternally administered Big endothelin-1 to endothelin-1
29. Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: possible physiological significance
30. Presence of a phosphoramidon-sensitive endothelin-converting enzyme which converts big-endothelin-1, but not big-endothelin-3, in the rat vas deferens
31. Regional differences in endothelin converting enzyme activity in rat brain: inhibition by phosphoramidon and EDTA
32. 2 and the vascular changes in inflammation
33. A novel potent vasoconstrictor peptide produced by vascular endothelial cells